Experimental: VID-KIDS Intervention Program Group for Depression, Postpartum

Phase-Based Progress Estimates
Depression, Postpartum+1 More
VID-KIDS Intervention Program - Behavioral
< 65
What conditions do you have?

Study Summary

This trial is investigating whether an in-person program designed to improve children's mental, emotional and behavioural health and development via parent-child relationship intervention can be delivered online.

Eligible Conditions
  • Depression, Postpartum
  • Postpartum Depression

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: through study completion, an average of 18 weeks

Week 18
Nursing Child Assessment Satellite Training (NCAST) assessment scale will be used to evaluate Mother-Infant (M-I) interactions

Trial Safety

Trial Design

1 Treatment Group

Experimental: VID-KIDS Intervention Program Group
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Experimental: VID-KIDS Intervention Program Group · No Placebo Group · N/A

Experimental: VID-KIDS Intervention Program Group
Experimental Group · 1 Intervention: VID-KIDS Intervention Program · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 18 weeks

Who is running the clinical trial?

University of CalgaryLead Sponsor
701 Previous Clinical Trials
492,791 Total Patients Enrolled
2 Trials studying Depression, Postpartum
430 Patients Enrolled for Depression, Postpartum
Alberta Health servicesOTHER
143 Previous Clinical Trials
305,434 Total Patients Enrolled
1 Trials studying Depression, Postpartum
400 Patients Enrolled for Depression, Postpartum
Nicole LetourneauPrincipal InvestigatorUniversity of Calgary

Eligibility Criteria

Age < 65 · Female Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 21st, 2021

Last Reviewed: November 11th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

How old are they?
18 - 65100.0%
What site did they apply to?
University of Calgary100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Typically responds via